Desvenlafaxine
- Product NDC
- 0591-3660
- 11-digit product format
- 005913660
- Labeler code
- 0591
- Product ID
- 0591-3660_9ae096b1-2fff-4410-b1c5-799171a05d54
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Desvenlafaxine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA204065
- Marketing category
- ANDA
- Marketing start
- 2017-03-01
- Substance
- DESVENLAFAXINE SUCCINATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Desvenlafaxine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DESVENLAFAXINE SUCCINATE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | ZB22ENF0XR |
| Rxcui | 1607617, 1874553, 1874559 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0591-3660-30 | Desvenlafaxine | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 27 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0591-3660 | DESVENLAFAXINE TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 26 | Current NDC, Legacy NDC, 1 package rows | 20240524_617476f9-62d7-40ef-a1b1-c349d4ad706f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0591-3660-30 | 00591366030 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-3660-30) | 2017-03-01 | 0000-00-00 | No | No | Current |